Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
 

Get Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss Accounts
Quarterly Results
Key Financial Ratios
Share Price
Charts
 
  
Quarterly Results
Aurobindo Pharma Ltd
    Industry   : Pharmaceuticals - Indian - Bulk Drugs & Formln  Chairman  : M R Kumar
    Home        : Indian Private  Book Value: 335.4746309
    BSE Code  : 524804  Market Cap: 61904.41
    NSE Code  : AUROPHARMA  P / E              : 32.29 

Change Company :
   Quarters: 
(Rs in Cr.)
Quarterly Results
ParticularsDec 2024Sep 2024Jun 2024Mar 2024
Type3Qtr2Qtr1Qtr4Qtr
Net Sales2883.562757.882425.222866.40
Other Income54.26122.6665.32122.97
Total Income2970.892947.252525.413017.00
Total Expenditure 2203.482103.711961.162119.24
Operating Profit767.41843.54564.25897.76
Interest66.1951.6351.1353.07
Gross Profit701.22791.91513.12844.69
Depreciation68.2868.1666.8864.81
Tax164.03188.43119.66207.66
Deferred Tax-3.14-2.21-2.46-6.45
Reported Profit After Tax472.05537.53329.04578.67
BSE Disclaimer     |     Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   | Risk Disclosure   | Rules and Regulations   |   Investor Charter   |   Investor Complaints   |   Smart ODR   |   Attention Investors   |

SEBI Saa₹thi Mobile App/SEBI Investor Website  
SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved Developed & Maintained By C-MOTS Infotech(ISO 9001:2015 certified)
Content powered by Capital Market Charts are powered by TradingView